Hu, Zhongjie

Publishing since 1986 (Dinosaur)

Has published 467 publications in 25 years

Number of publications published per year by Hu, Zhongjie. (Source : PubMed)

Distribution of publications types for Hu, Zhongjie. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Wang Y, Zhai C, Niu L, Tian L, Yang J, Hu Z. Retrospective series of subtotal colonic bypass and antiperistaltic cecoproctostomy for the treatment of slow-transit constipation.  Int J Colorectal Dis  2010;25;5  
•  Wang Y, Zhai C, Niu L, Tian L, Yang J, Hu Z. A modified Delorme's operation for the treatment of rectal mucosal prolapse.  Int J Colorectal Dis  2010;25;5  
•  Qian N, Chen X, Han S, Qiang F, Jin G, Zhou X, Dong J, Wang X, Shen H, Hu Z. Circulating IL-1beta levels, polymorphisms of IL-1B, and risk of cervical cancer in Chinese women.  J. Cancer Res. Clin. Oncol.  2010;136;5  
•  Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, Chen Y, Xu L, Zen K, Zhang C, Shen H. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.  J. Clin. Oncol.  2010;28;10  
•  Hu Z, Li X, Qu X, He Y, Ring BZ, Song E, Su L. Intron 3 16 bp duplication polymorphism of TP53 contributes to cancer susceptibility: a meta-analysis.  Carcinogenesis  2010;31;4  
•  Hu Z, Ou Y, Duan K, Jiang X. Inflammation: a bridge between postoperative cognitive dysfunction and Alzheimer's disease.  Med. Hypotheses  2010;74;4  
•  Hu Z, Robbins JS, Pister A, Zafar MB, Zhang ZW, Gupta J, Lee KJ, Neuman K, Yun CO, Guise T, Seth P. A modified hTERT promoter-directed oncolytic adenovirus replication with concurrent inhibition of TGFbeta signaling for breast cancer therapy.  Cancer Gene Ther.  2010;17;4  
•  Xu Y, Liu L, Liu J, Zhang Y, Zhu J, Chen J, Liu S, Liu Z, Shi H, Shen H, Hu Z. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma.  Int. J. Cancer  2010  
•  Yan Y, Hu Z, Zhao X, Sun T, Dong S, Li X. Top-down nanomechanical machining of three-dimensional nanostructures by atomic force microscopy.  Small  2010;6;6  
•  Guo H, Bai Y, Xu P, Hu Z, Liu L, Wang F, Jin G, Wang F, Deng Q, Tu Y, Feng M, Lu D, Shen H, Wu T. Functional Promoter -1271G>C Variant of HSPB1 Predicts Lung Cancer Risk and Survival.  J. Clin. Oncol.  2010  

[ See timeline ] [ See all publications ]